BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31017330)

  • 1. Non-inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells.
    Karpov AA; Puzanov MV; Ivkin DY; Krasnova MV; Anikin NA; Docshin PM; Moiseeva OM; Galagudza MM
    Int J Exp Pathol; 2019 Apr; 100(2):102-113. PubMed ID: 31017330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.
    Wright EJ; Farrell KA; Malik N; Kassem M; Lewis AL; Wallrapp C; Holt CM
    Stem Cells Transl Med; 2012 Oct; 1(10):759-69. PubMed ID: 23197668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.
    Gnecchi M; He H; Noiseux N; Liang OD; Zhang L; Morello F; Mu H; Melo LG; Pratt RE; Ingwall JS; Dzau VJ
    FASEB J; 2006 Apr; 20(6):661-9. PubMed ID: 16581974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
    Hu X; Xu Y; Zhong Z; Wu Y; Zhao J; Wang Y; Cheng H; Kong M; Zhang F; Chen Q; Sun J; Li Q; Jin J; Li Q; Chen L; Wang C; Zhan H; Fan Y; Yang Q; Yu L; Wu R; Liang J; Zhu J; Wang Y; Jin Y; Lin Y; Yang F; Jia L; Zhu W; Chen J; Yu H; Zhang J; Wang J
    Circ Res; 2016 Mar; 118(6):970-83. PubMed ID: 26838793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction.
    Tang J; Wang J; Guo L; Kong X; Yang J; Zheng F; Zhang L; Huang Y
    Mol Cells; 2010 Jan; 29(1):9-19. PubMed ID: 20016947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors.
    Nguyen BK; Maltais S; Perrault LP; Tanguay JF; Tardif JC; Stevens LM; Borie M; Harel F; Mansour S; Noiseux N
    J Cardiovasc Transl Res; 2010 Oct; 3(5):547-58. PubMed ID: 20559784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function.
    Otto Beitnes J; Oie E; Shahdadfar A; Karlsen T; Müller RM; Aakhus S; Reinholt FP; Brinchmann JE
    Cell Transplant; 2012; 21(8):1697-709. PubMed ID: 22410280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
    Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
    Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury.
    Zuo S; Jones WK; Li H; He Z; Pasha Z; Yang Y; Wang Y; Fan GC; Ashraf M; Xu M
    Stem Cells Dev; 2012 Mar; 21(4):598-608. PubMed ID: 21463175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of microencapsulated Schwann cells and mesenchymal stem cells augment angiogenesis and improve heart function.
    Wang Y; Zhang G; Hou Y; Chen J; Wang J; Zou C; Li D; Li H; Zhang Q; Wang A; Fan Q
    Mol Cell Biochem; 2012 Jul; 366(1-2):139-47. PubMed ID: 22488214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
    Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury.
    Liang H; Hou H; Yi W; Yang G; Gu C; Lau WB; Gao E; Ma X; Lu Z; Wei X; Pei J; Yi D
    Eur Heart J; 2013 Jun; 34(22):1681-90. PubMed ID: 21606086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
    Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
    Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms.
    Duran JM; Makarewich CA; Sharp TE; Starosta T; Zhu F; Hoffman NE; Chiba Y; Madesh M; Berretta RM; Kubo H; Houser SR
    Circ Res; 2013 Aug; 113(5):539-52. PubMed ID: 23801066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine role for mesenchymal stem cells in acute myocardial infarction.
    Li Z; Guo J; Chang Q; Zhang A
    Biol Pharm Bull; 2009 Aug; 32(8):1343-6. PubMed ID: 19652371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.